Invesco Biotechnology & Genome ETF (PBE)
NYSEARCA: PBE · Real-Time Price · USD
72.05
+0.12 (0.16%)
Oct 8, 2025, 4:00 PM EDT - Market closed
PBE Holdings Information
PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Biogen stock at 5.48%, Vertex Pharmaceuticals at 4.89%, Illumina at 4.85%, Incyte at 4.85%, and Amgen at 4.82%.
Total Holdings
33
Top 10 Percentage
46.92%
Asset Class
Equity
ETF Category
Health
Assets
227.71M
PE Ratio
18.09
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | BIIB | Biogen Inc. | 5.48% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 4.89% |
| 3 | ILMN | Illumina, Inc. | 4.85% |
| 4 | INCY | Incyte Corporation | 4.85% |
| 5 | AMGN | Amgen Inc. | 4.82% |
| 6 | REGN | Regeneron Pharmaceuticals, Inc. | 4.79% |
| 7 | RPRX | Royalty Pharma plc | 4.70% |
| 8 | GILD | Gilead Sciences, Inc. | 4.60% |
| 9 | IONS | Ionis Pharmaceuticals, Inc. | 4.19% |
| 10 | UTHR | United Therapeutics Corporation | 3.75% |
| 11 | MNKD | MannKind Corporation | 3.62% |
| 12 | PTCT | PTC Therapeutics, Inc. | 3.38% |
| 13 | SRPT | Sarepta Therapeutics, Inc. | 3.17% |
| 14 | VCYT | Veracyte, Inc. | 3.17% |
| 15 | EXAS | Exact Sciences Corporation | 3.15% |
| 16 | TECH | Bio-Techne Corporation | 2.83% |
| 17 | EXEL | Exelixis, Inc. | 2.67% |
| 18 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.67% |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 2.67% |
| 20 | NBIX | Neurocrine Biosciences, Inc. | 2.56% |
| 21 | DVAX | Dynavax Technologies Corporation | 2.47% |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 2.47% |
| 23 | QGEN | Qiagen N.V. | 2.45% |
| 24 | HALO | Halozyme Therapeutics, Inc. | 2.42% |
| 25 | AKBA | Akebia Therapeutics, Inc. | 2.34% |
As of Oct 3, 2025